Effect of maternal smoking on prenatal screening for Down syndrome and trisomy 18 in the first trimester of pregnancy

Prenatal Diagnosis

Volumn 28, Issue 3, 2008, Pages 180-185

  Miron, Pierre ^a,b   Côté, Yvan P ^c   Lambert, Jean ^d  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b Prenagen Inc   (Canada)

^c Warnex Medical Laboratories   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Beta subunit; Chorionic gonadotrophin; Down syndrome; Human; Nuchal translucency measurement; Pregnancy associated plasma protein A; Smoking; Trisomy

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; DISEASE MARKER; DOWN SYNDROME; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SMOKING; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; TRISOMY 18;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; MATERNAL BEHAVIOR; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; SMOKING; TRISOMY;

EID: 41149100507     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1930     Document Type: Article

References (31)

1. Ardawi M, Nasrat H, Rouzi A, Qari M, Al-Qahtani M, Abuzenadah A. 2007a. The effect of cigarette or sheesha smoking on first-trimester markers of Down syndrome. BJOG 114: 1397-1401.
2. Ardawi MS, Nasrat HA, Rouzi AA, Qari MH, Al-Qahtani MH, Abuzenadah AM. 2007b. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women. Prenat Diagn 27: 303-311.
3. Bartels I, Hoppe-Sievert B, Bockel B, Herold S, Caesar J. 1993. Adjustment formulae for maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weight and smoking. Prenat Diagn 13: 123-130.
4. Bekker MN, Van Den Akker NM, Bartelings MM, et al. 2006. Nuchal edema and venous-lymphatic phenotype disturbance in human fetuses and mouse embryos with aneuploidy. J Soc Gynecol Investig 13: 209-216.
5. Brandenburg H, Steegers EA, Gittenberger-de Groot AC. 2005. Potential involvement of vascular endomelial growth factor in pathophysiology of Turner syndrome. Med Hypotheses 65: 300-304.
6. Cuckle HS, Alberman E, Wald NJ, Royston P, Knight G. 1990. Maternal smoking habits and Down's syndrome. Prenat Diagn 10: 561-567.
7. de Graaf IM, Cuckle HS, Pajkrt E, Leschot NJ, Bleker OP, van Lith JM. 2000. Co-variables in first trimester maternal serum screening. Prenat Diagn 20: 186-189.
8. DeMarini DM. 2004. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 567: 447-474.
9. Ferriman EL, Sehmi IK, Jones R, Cuckle HS. 1999. The effect of smoking in pregnancy on maternal serum inhibin A levels. Prenat Diagn 19: 372-374.
10. George L, Granath F, Johansson AL, Cnattingius S. 2006. Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet Gynecol Scand 85: 1331-1337.
11. Goodman GE, Thornquist M, Kestin M, Metch B, Anderson G, Omenn GS. 1996. The association between participant characteristics and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung cancer. Cancer Epidemiol Biomarkers Prev 5: 815-821.
12. Grange G, Borgne A, Ouazana A, et al. 2006. Prevalence of smoking cessation during pregnancy according to trimester. Gynecol Obstet Fertil 34: 1126-1130.
13. Harkonen K, Viitanen T, Larsen SB, Bonde JP, Lahdetie J. 1999. Aneuploidy in sperm and exposure to fungicides and lifestyle factors. ASCLEPIOS. A European Concerted Action on Occupational Hazards to Male Reproductive Capability. Environ Mol Mutagen 34: 39-46.
14. ISQ. 2006. La situation démographique au Québec. Bilan 2006. Bibliothèque et archives nationales du Québec.
15. Kagan KO, Frisova V, Nicolaides KH, Spencer K. 2007. Dose dependency between cigarette consumption and reduced maternal serum PAPP-A levels at 11-13(+6) weeks of gestation. Prenat Diagn 27: 849-853.
16. Krantz DA, Hallahan TW, Macri VJ, Macri JN. 2005. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program. Prenat Diagn 25: 635-640.
17. Krantz DA, Hallahan TW, Orlandi F, Buchanan P, Larsen JW Jr, Macri JN. 2000. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol 96: 207-213.
18. L'Hermine-Coulomb A. 2005. Increased nuchal translucency pathophysiology. J Gynecol Obstet Biol Reprod (Paris) 34: S89-S96.
19. Lindqvist R, Lendahls L, Tollbom O, Aberg H, Hakansson A. 2002. Smoking during pregnancy: comparison of self-reports and cotinine levels in 496 women. Acta Obstet Gynecol Scand 81: 240-244.
20. Niemimaa M, Heinonen S, Seppala M, Ryynanen M. 2003. The influence of smoking on the pregnancy-associated plasma protein A, free beta human chorionic gonadotrophin and nuchal translucency. BJOG 110: 664-667.
21. Palomaki GE, Knight GJ, Haddow JE, Canick JA, Wald NJ, Kennard A. 1993. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening. Obstet Gynecol 81: 675-678.
22. Rodger RS, Laker MF, Fletcher K, et al. 1985. Factors influencing normal reference intervals for creatinine, urea, and electrolytes in plasma, as measured with a Beckman Astra 8 Analyzer. Clin Chem 31: 292-295.
23. Rubes J, Lowe X, Moore D 2nd, et al. 1998. Smoking cigarettes is associated with increased sperm disomy in teenage men. Fertil Steril 70: 715-723.
24. Rudnicka AR, Wald NJ, Huttly W, Hackshaw AK. 2002. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. Prenat Diagn 22: 893-897.
25. Shi Q, Ko E, Barclay L, Hoang T, Rademaker A, Martin R. 2001. Cigarette smoking and aneuploidy in human sperm. Mol Reprod Dev 59: 417-421.
26. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 352: 343-346.
27. Spencer K. 1998. The influence of smoking on maternal serum AFP and free beta hCG levels and the impact on screening for Down syndrome. Prenat Diagn 18: 225-234.
28. Spencer K, Bindra R, Cacho AM, Nicolaides KH. 2004. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 24: 169-173.
29. Yigiter AB, Kavak ZN, Bakirci N, Gokaslan H. 2006. Effect of smoking on pregnancy-associated plasma protein A, free beta-human chorionic gonadotropin, and nuchal translucency in the first trimester of pregnancy. Adv Ther 23: 131-138.
30. Zdravkovic T, Genbacev O, McMaster MT, Fisher SJ. 2005. The adverse effects of maternal smoking on the human placenta: a review. Placenta 26(Suppl. A): S81-S86.
31. Zenzes MT. 2000. Smoking and reproduction: gene damage to human gametes and embryos. Hum Reprod Update 6: 122-131.